A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid Tumors

Trial Profile

A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid Tumors

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs SEphB4-HSA (Primary) ; Cisplatin; Docetaxel; Gemcitabine; Paclitaxel
  • Indications Adenocarcinoma; Gallbladder cancer; Head and neck cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jul 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
    • 15 Jul 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
    • 08 Sep 2015 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2017 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top